<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26(24)</volume><submitter>Kim WJ</submitter><pubmed_abstract>The signaling lipid molecule 15-deoxy-delta 12,14-prostaglandin J2 (15d-PGJ2) has multiple cellular functions, including anti-inflammatory and antineoplastic activities. Here, we report that 15d-PGJ2 blocks translation through inactivation of translational initiation factor eIF4A. Binding of 15d-PGJ2 to eIF4A blocks the interaction between eIF4A and eIF4G that is essential for translation of many mRNAs. Cysteine 264 in eIF4A is the target site of 15d-PGJ2. The antineoplastic activity of 15d-PGJ2 is likely attributed to inhibition of translation. Moreover, inhibition of translation by 15d-PGJ2 results in stress granule (SG) formation, into which TRAF2 is sequestered. The sequestration of TRAF2 contributes to the anti-inflammatory activity of 15d-PGJ2. These findings reveal a novel cross-tal</pubmed_abstract><journal>The EMBO journal</journal><pagination>5020-32</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2140107</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.</pubmed_title><pmcid>PMC2140107</pmcid><pubmed_authors>Kim WJ</pubmed_authors><pubmed_authors>Jang SK</pubmed_authors><pubmed_authors>Kim JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.</name><description>The signaling lipid molecule 15-deoxy-delta 12,14-prostaglandin J2 (15d-PGJ2) has multiple cellular functions, including anti-inflammatory and antineoplastic activities. Here, we report that 15d-PGJ2 blocks translation through inactivation of translational initiation factor eIF4A. Binding of 15d-PGJ2 to eIF4A blocks the interaction between eIF4A and eIF4G that is essential for translation of many mRNAs. Cysteine 264 in eIF4A is the target site of 15d-PGJ2. The antineoplastic activity of 15d-PGJ2 is likely attributed to inhibition of translation. Moreover, inhibition of translation by 15d-PGJ2 results in stress granule (SG) formation, into which TRAF2 is sequestered. The sequestration of TRAF2 contributes to the anti-inflammatory activity of 15d-PGJ2. These findings reveal a novel cross-tal</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Dec</publication><modification>2025-04-18T19:31:29.849Z</modification><creation>2019-03-27T02:22:09Z</creation></dates><accession>S-EPMC2140107</accession><cross_references><pubmed>18034160</pubmed><doi>10.1038/sj.emboj.7601920</doi></cross_references></HashMap>